Cases 31 - 40 of 487
Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals, Inc. et al
as 1:2022cv00513
Plaintiff:
Otsuka Pharmaceutical Co., Ltd.
Defendant:
Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
EVOKE PHARMA, INC. v. TEVA PHARMACEUTICALS INC. et al
as 1:2022cv02019
Plaintiff:
EVOKE PHARMA, INC.
Defendant:
TEVA PHARMACEUTICALS INC. and TEVA PHARMACEUTICAL USA, INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Journey Medical Corporation et al v. Teva Pharmaceuticals, Inc. et al
as 1:2022cv00288
Plaintiff:
Journey Medical Corporation and Rose U, LLC
Defendant:
Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2022cv00221
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Teva Pharmaceuticals USA, Inc.
as 1:2022cv00192
Plaintiff:
Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V. and others
Defendant:
Teva Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc. et al
as 1:2022cv00083
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271
Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2022cv00092
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Novo Nordisk Inc. et al v. Teva Pharmaceuticals, Inc. et al
as 1:2021cv01782
Defendant:
Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc.
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Cause Of Action: 35 U.S.C. § 271
Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.
as 22-1258
Plaintiff / Appellee:
JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant / Appellant:
TEVA PHARMACEUTICALS USA, INC., MYLAN LABORATORIES LIMITED and MYLAN LABORATORIES LTD.
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
